TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 102 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $706,000 | -17.3% | 152,502 | +609.5% | 0.10% | +25.9% |
| Q4 2014 | $854,000 | -67.8% | 21,495 | -83.8% | 0.08% | -64.8% |
| Q3 2014 | $2,655,000 | +159.0% | 133,070 | +75.2% | 0.23% | +184.0% |
| Q2 2014 | $1,025,000 | +131.4% | 75,964 | +86.9% | 0.08% | +179.3% |
| Q1 2014 | $443,000 | -44.9% | 40,654 | -31.6% | 0.03% | -23.7% |
| Q4 2013 | $804,000 | +281.0% | 59,470 | +220.7% | 0.04% | +280.0% |
| Q3 2013 | $211,000 | – | 18,546 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 600,000 | $2,142,000 | 0.14% |
| Tekla Capital Management LLC | 859,322 | $3,068,000 | 0.12% |
| DOW CHEMICAL CO /DE/ | 65,000 | $232,000 | 0.08% |
| Candriam S.C.A. | 495,613 | $1,769,000 | 0.03% |
| A.R.T. Advisors, LLC | 174,335 | $622,000 | 0.02% |
| Baker Brothers Advisors | 935,000 | $3,338,000 | 0.02% |
| FLAGSHIP HARBOR ADVISORS, LLC | 29,400 | $104,000 | 0.02% |
| Alambic Investment Management, L.P. | 17,804 | $64,000 | 0.02% |
| Teton Advisors, Inc. | 44,000 | $157,000 | 0.01% |
| Man Group plc | 737,715 | $2,634,000 | 0.01% |